Department of Medicine, Upstate Medical University, State University of New York, Syracuse, NY, USA.
Am Heart J. 2010 Mar;159(3):399-405. doi: 10.1016/j.ahj.2009.12.010.
Central aortic systolic blood pressures (SBPs) differ from and are preferable to cuff pressures when calculating cardiac work, left ventricular wall stress, and rate-pressure product. Despite the widespread use of dobutamine, differences between aortic and brachial SBP (pulse amplification) and pulse transmission during dobutamine infusion have not been previously studied. This study assessed these differences and used applanated radial pulses with the Sphygmocor (AtCor Medical, Sydney, Australia) device to investigate the effects of dobutamine on arterial pulse transmission and pulse amplification.
Using a cuff oscillometer, brachial arterial pressures were measured simultaneously with directly recorded aortic pressures at rest and during increasing dobutamine infusion rates in 25 patients. In 15 of those patients, applanated radial pulses were fed into the Sphygmocor device and calibrated in 2 ways to predict aortic pressures.
At peak dobutamine infusion, SBP amplification averaged 14.9 mm Hg, with a maximum difference of 43 mm Hg. When radial artery pulses were calibrated using cuff pressures, the Sphygmocor underestimated the aortic SBP at all dobutamine doses. However, when radial artery pulses were calibrated using the more accurate aortic mean and diastolic BPs, the Sphygmocor accurately predicted the aortic SBP at baseline, but not at the higher dobutamine doses.
Similar to exercise, dobutamine induced cuff SBPs and pulse pressures higher than those measured in the aorta-uncorrected by the cuff-calibrated Sphygmocor. This increasing pulse amplification was explained by the effects of dobutamine on the properties of the conduit arterial walls, on changes in pulse wave velocity, on increasing heart rate, and on reflected waves.
在计算心脏做功、左心室壁应力和心率-血压乘积时,主动脉收缩压(SBP)与袖带压不同,且优于袖带压。尽管多巴酚丁胺的应用广泛,但在多巴酚丁胺输注期间,主动脉和肱动脉 SBP(脉搏放大)和脉搏传递之间的差异尚未被研究过。本研究评估了这些差异,并使用 Sphygmocor(澳大利亚悉尼 AtCor Medical 公司)设备上的平板桡动脉脉搏来研究多巴酚丁胺对动脉脉搏传递和脉搏放大的影响。
使用袖带测振仪,在 25 例患者中,在静息状态下和逐渐增加多巴酚丁胺输注率期间,同时测量肱动脉动脉压和直接记录的主动脉压力。在其中 15 例患者中,将平板桡动脉脉搏输入 Sphygmocor 设备,并以 2 种方式进行校准,以预测主动脉压力。
在多巴酚丁胺输注的峰值时,SBP 放大平均为 14.9mmHg,最大差异为 43mmHg。当使用袖带压力校准桡动脉脉搏时,Sphygmocor 在所有多巴酚丁胺剂量下均低估了主动脉 SBP。然而,当使用更准确的主动脉平均压和舒张压校准桡动脉脉搏时,Sphygmocor 可准确预测基础状态下的主动脉 SBP,但不能预测更高剂量的多巴酚丁胺。
与运动相似,多巴酚丁胺引起的袖带 SBP 和脉搏压高于在主动脉中测量的值-未被袖带校准的 Sphygmocor 校正。这种不断增加的脉搏放大是由多巴酚丁胺对输送动脉壁特性的影响、脉搏波速度的变化、心率的增加以及反射波引起的。